Report Detail

Pharma & Healthcare Global Pharmaceutical CMO Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM3977436
  • |
  • 19 February, 2023
  • |
  • Global
  • |
  • 110 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pharmaceutical CMO Services market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Pharmaceutical CMO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pharmaceutical CMO Services market size and forecasts, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CMO Services market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CMO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CMO Services market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical CMO Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical CMO Services market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Boehringer Ingelheim, FUJIFILM Diosynth Biotechnologies, AGC Chemicals and AbbVie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Pharmaceutical CMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Active Pharmaceutical Ingredients (APIs)
Finished Dose Formulations (FDFs)
Packaging
Market segment by Application
Pharmaceutical Industry
Biotechnology Industry
Market segment by players, this report covers
Lonza
Boehringer Ingelheim
FUJIFILM Diosynth Biotechnologies
AGC Chemicals
AbbVie
Pfizer
Evonik Health Care
Delpharm
Recipharm
Teva API
Catalent
Esteve Quimica
Fareva
Patheon
Piramal
Hisun Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmaceutical CMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical CMO Services, with revenue, gross margin and global market share of Pharmaceutical CMO Services from 2018 to 2023.
Chapter 3, the Pharmaceutical CMO Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pharmaceutical CMO Services market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical CMO Services.
Chapter 13, to describe Pharmaceutical CMO Services research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Pharmaceutical CMO Services
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Pharmaceutical CMO Services by Type
    • 1.3.1 Overview: Global Pharmaceutical CMO Services Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Pharmaceutical CMO Services Consumption Value Market Share by Type in 2022
    • 1.3.3 Active Pharmaceutical Ingredients (APIs)
    • 1.3.4 Finished Dose Formulations (FDFs)
    • 1.3.5 Packaging
  • 1.4 Global Pharmaceutical CMO Services Market by Application
    • 1.4.1 Overview: Global Pharmaceutical CMO Services Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Pharmaceutical Industry
    • 1.4.3 Biotechnology Industry
  • 1.5 Global Pharmaceutical CMO Services Market Size & Forecast
  • 1.6 Global Pharmaceutical CMO Services Market Size and Forecast by Region
    • 1.6.1 Global Pharmaceutical CMO Services Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Pharmaceutical CMO Services Market Size by Region, (2018-2029)
    • 1.6.3 North America Pharmaceutical CMO Services Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Pharmaceutical CMO Services Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Pharmaceutical CMO Services Market Size and Prospect (2018-2029)
    • 1.6.6 South America Pharmaceutical CMO Services Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Pharmaceutical CMO Services Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Lonza
    • 2.1.1 Lonza Details
    • 2.1.2 Lonza Major Business
    • 2.1.3 Lonza Pharmaceutical CMO Services Product and Solutions
    • 2.1.4 Lonza Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Lonza Recent Developments and Future Plans
  • 2.2 Boehringer Ingelheim
    • 2.2.1 Boehringer Ingelheim Details
    • 2.2.2 Boehringer Ingelheim Major Business
    • 2.2.3 Boehringer Ingelheim Pharmaceutical CMO Services Product and Solutions
    • 2.2.4 Boehringer Ingelheim Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.3 FUJIFILM Diosynth Biotechnologies
    • 2.3.1 FUJIFILM Diosynth Biotechnologies Details
    • 2.3.2 FUJIFILM Diosynth Biotechnologies Major Business
    • 2.3.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Product and Solutions
    • 2.3.4 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
  • 2.4 AGC Chemicals
    • 2.4.1 AGC Chemicals Details
    • 2.4.2 AGC Chemicals Major Business
    • 2.4.3 AGC Chemicals Pharmaceutical CMO Services Product and Solutions
    • 2.4.4 AGC Chemicals Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 AGC Chemicals Recent Developments and Future Plans
  • 2.5 AbbVie
    • 2.5.1 AbbVie Details
    • 2.5.2 AbbVie Major Business
    • 2.5.3 AbbVie Pharmaceutical CMO Services Product and Solutions
    • 2.5.4 AbbVie Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 AbbVie Recent Developments and Future Plans
  • 2.6 Pfizer
    • 2.6.1 Pfizer Details
    • 2.6.2 Pfizer Major Business
    • 2.6.3 Pfizer Pharmaceutical CMO Services Product and Solutions
    • 2.6.4 Pfizer Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Pfizer Recent Developments and Future Plans
  • 2.7 Evonik Health Care
    • 2.7.1 Evonik Health Care Details
    • 2.7.2 Evonik Health Care Major Business
    • 2.7.3 Evonik Health Care Pharmaceutical CMO Services Product and Solutions
    • 2.7.4 Evonik Health Care Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Evonik Health Care Recent Developments and Future Plans
  • 2.8 Delpharm
    • 2.8.1 Delpharm Details
    • 2.8.2 Delpharm Major Business
    • 2.8.3 Delpharm Pharmaceutical CMO Services Product and Solutions
    • 2.8.4 Delpharm Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Delpharm Recent Developments and Future Plans
  • 2.9 Recipharm
    • 2.9.1 Recipharm Details
    • 2.9.2 Recipharm Major Business
    • 2.9.3 Recipharm Pharmaceutical CMO Services Product and Solutions
    • 2.9.4 Recipharm Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Recipharm Recent Developments and Future Plans
  • 2.10 Teva API
    • 2.10.1 Teva API Details
    • 2.10.2 Teva API Major Business
    • 2.10.3 Teva API Pharmaceutical CMO Services Product and Solutions
    • 2.10.4 Teva API Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Teva API Recent Developments and Future Plans
  • 2.11 Catalent
    • 2.11.1 Catalent Details
    • 2.11.2 Catalent Major Business
    • 2.11.3 Catalent Pharmaceutical CMO Services Product and Solutions
    • 2.11.4 Catalent Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Catalent Recent Developments and Future Plans
  • 2.12 Esteve Quimica
    • 2.12.1 Esteve Quimica Details
    • 2.12.2 Esteve Quimica Major Business
    • 2.12.3 Esteve Quimica Pharmaceutical CMO Services Product and Solutions
    • 2.12.4 Esteve Quimica Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Esteve Quimica Recent Developments and Future Plans
  • 2.13 Fareva
    • 2.13.1 Fareva Details
    • 2.13.2 Fareva Major Business
    • 2.13.3 Fareva Pharmaceutical CMO Services Product and Solutions
    • 2.13.4 Fareva Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Fareva Recent Developments and Future Plans
  • 2.14 Patheon
    • 2.14.1 Patheon Details
    • 2.14.2 Patheon Major Business
    • 2.14.3 Patheon Pharmaceutical CMO Services Product and Solutions
    • 2.14.4 Patheon Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Patheon Recent Developments and Future Plans
  • 2.15 Piramal
    • 2.15.1 Piramal Details
    • 2.15.2 Piramal Major Business
    • 2.15.3 Piramal Pharmaceutical CMO Services Product and Solutions
    • 2.15.4 Piramal Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Piramal Recent Developments and Future Plans
  • 2.16 Hisun Pharmaceuticals
    • 2.16.1 Hisun Pharmaceuticals Details
    • 2.16.2 Hisun Pharmaceuticals Major Business
    • 2.16.3 Hisun Pharmaceuticals Pharmaceutical CMO Services Product and Solutions
    • 2.16.4 Hisun Pharmaceuticals Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Hisun Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Pharmaceutical CMO Services Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Pharmaceutical CMO Services by Company Revenue
    • 3.2.2 Top 3 Pharmaceutical CMO Services Players Market Share in 2022
    • 3.2.3 Top 6 Pharmaceutical CMO Services Players Market Share in 2022
  • 3.3 Pharmaceutical CMO Services Market: Overall Company Footprint Analysis
    • 3.3.1 Pharmaceutical CMO Services Market: Region Footprint
    • 3.3.2 Pharmaceutical CMO Services Market: Company Product Type Footprint
    • 3.3.3 Pharmaceutical CMO Services Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Pharmaceutical CMO Services Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Pharmaceutical CMO Services Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Pharmaceutical CMO Services Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Pharmaceutical CMO Services Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Pharmaceutical CMO Services Consumption Value by Type (2018-2029)
  • 6.2 North America Pharmaceutical CMO Services Consumption Value by Application (2018-2029)
  • 6.3 North America Pharmaceutical CMO Services Market Size by Country
    • 6.3.1 North America Pharmaceutical CMO Services Consumption Value by Country (2018-2029)
    • 6.3.2 United States Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Pharmaceutical CMO Services Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Pharmaceutical CMO Services Consumption Value by Type (2018-2029)
  • 7.2 Europe Pharmaceutical CMO Services Consumption Value by Application (2018-2029)
  • 7.3 Europe Pharmaceutical CMO Services Market Size by Country
    • 7.3.1 Europe Pharmaceutical CMO Services Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
    • 7.3.3 France Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Pharmaceutical CMO Services Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Pharmaceutical CMO Services Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Pharmaceutical CMO Services Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Pharmaceutical CMO Services Market Size by Region
    • 8.3.1 Asia-Pacific Pharmaceutical CMO Services Consumption Value by Region (2018-2029)
    • 8.3.2 China Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
    • 8.3.5 India Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Pharmaceutical CMO Services Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Pharmaceutical CMO Services Consumption Value by Type (2018-2029)
  • 9.2 South America Pharmaceutical CMO Services Consumption Value by Application (2018-2029)
  • 9.3 South America Pharmaceutical CMO Services Market Size by Country
    • 9.3.1 South America Pharmaceutical CMO Services Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Pharmaceutical CMO Services Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Pharmaceutical CMO Services Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Pharmaceutical CMO Services Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Pharmaceutical CMO Services Market Size by Country
    • 10.3.1 Middle East & Africa Pharmaceutical CMO Services Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Pharmaceutical CMO Services Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Pharmaceutical CMO Services Market Drivers
  • 11.2 Pharmaceutical CMO Services Market Restraints
  • 11.3 Pharmaceutical CMO Services Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Pharmaceutical CMO Services Industry Chain
  • 12.2 Pharmaceutical CMO Services Upstream Analysis
  • 12.3 Pharmaceutical CMO Services Midstream Analysis
  • 12.4 Pharmaceutical CMO Services Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Pharmaceutical CMO Services. Industry analysis & Market Report on Pharmaceutical CMO Services is a syndicated market report, published as Global Pharmaceutical CMO Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Pharmaceutical CMO Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,208.56
    4,812.84
    6,417.12
    531,604.80
    797,407.20
    1,063,209.60
    292,702.80
    439,054.20
    585,405.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report